GI
AURA icon

GAMMA Investing’s Aura Biosciences AURA Stock Holding History

GAMMA Investing’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.43K Buy
1,047
+187
+22% +$1.34K ﹤0.01% 3329
2026
Q1 		$5.75K Buy
860
+819
+1,998% +$4.7K ﹤0.01% 3316
2025
Q4 		$223 Sell
41
-564
-93% -$3.35K ﹤0.01% 3990
2025
Q3 		$3.74K Hold
605
– – ﹤0.01% 3281
2025
Q2 		$3.79K Sell
605
-1,057
-64% -$6.18K ﹤0.01% 3220
2025
Q1 		$9.74K Buy
1,662
+1,496
+901% +$11.3K ﹤0.01% 2754
2024
Q4 		$1.36K Buy
166
+141
+564% +$1.33K ﹤0.01% 3335
2024
Q3 		$223 Buy
+25
New +$214 ﹤0.01% 3484

Other funds holding AURA

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

GAMMA Investing's AURA Position: Q2 2026 in Review

GAMMA Investing increased its Aura Biosciences (AURA) stake by 22% in Q2 2026, buying an estimated $1.34K and bringing the position to 1,047 shares worth $7.43K. The position accounts for ﹤0.01% of the portfolio, ranked #3329.

GAMMA Investing first reported a position in AURA in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.74K in Q1 2025. 9 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • GAMMA Investing held 1,047 shares of Aura Biosciences worth $7.43K as of Q2 2026.
  • GAMMA Investing bought 187 Aura Biosciences shares in Q2 2026, an estimated $1.34K.
  • Aura Biosciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3329 holding.
  • GAMMA Investing first reported a position in Aura Biosciences in Q3 2024 and has held it in 8 quarters since.
  • GAMMA Investing's Aura Biosciences position peaked at $9.74K in Q1 2025.
  • 9 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.